NAVI Large & Midcap Fund
The scheme seeks to generate medium to long-term capital appreciation by investing predominantly in equity and equity related securities of midcap companies & large cap companies.
Growthvine rating: 1/5 — ranked #34 of 39 in category.
Fund basics
| Category | Equity: Large & Mid Cap |
|---|
| NAV | ₹37.28 (as of 2026-08-21) |
|---|
| AUM | ₹310 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Ashutosh Shirwaikar |
|---|
| Exit load | 0 |
|---|
Performance & risk
| 5-year annualised return | 11.06% |
|---|
| Sharpe ratio | 0.27 |
|---|
| Standard deviation | 16.83% |
|---|
| Max drawdown | -38.55% |
|---|
| Alpha | -2.94 |
|---|
| Beta | 1.07 |
|---|
Over 5 years, captured 91.2% of NIFTY LargeMidcap 250's upside and 105.0% of its downside.
Market cap allocation
| Large cap | 42.2% |
|---|
| Mid cap | 39.0% |
|---|
| Small cap | 18.8% |
|---|
Concentration
| Top 5 holdings | 14.9% |
|---|
| Top 10 holdings | 26.6% |
|---|
| Total holdings | 80 |
|---|
| Index overlap | 34.9% |
|---|
| Active share | 65.1% |
|---|
Top holdings
- TREPS/Reverse Repo/Net Current Assets/Cash/Cash Equivalent — 5.1%
- Federal Bank Ltd. — 3.3%
- AXIS Bank Ltd. — 3.0%
- HDFC Bank Ltd. — 2.9%
- ASTRAL LIMITED — 2.9%
- UPL Limited — 2.7%
- Kotak Mahindra Bank Ltd. — 2.5%
- ICICI Bank Ltd. — 2.4%
- Apollo Hospitals Enterprises Ltd. — 2.3%
- Samvardhana Motherson International Limited — 2.3%
Top sectors
- Banking & Financial — 28.4%
- Industrial Products — 8.6%
- Healthcare — 8.3%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 3.9% | Q2 | #13 of 38 |
| 2025 | 1.3% | Q4 (Bottom) | #27 of 34 |
| 2024 | 16.1% | Q4 (Bottom) | #24 of 29 |
| 2023 | 23.5% | Q4 (Bottom) | #27 of 28 |
| 2022 | 0.3% | Q3 | #17 of 28 |